Experience with sunitinib in the treatment of metastatic renal cell carcinoma
Therapeutic Advances in Urology, 07/25/2012
Clinical Article
Schmidinger M et al. – An increasing body of evidence suggests that side effects associated with sunitinib therapy, including hypertension, hand–foot syndrome and hypothyroidism, may represent effective markers of treatment response, and these will also be discussed.



